Literature DB >> 19188687

The telomeric transcriptome and SMG proteins at the crossroads.

R Chawla1, C M Azzalin.   

Abstract

Telomeres constitute the heterochromatic structures at the ends of linear eukaryotic chromosomes and are essential for the maintenance of genome stability. The longstanding belief that telomeres are transcriptionally silent has recently been overturned by the discovery of a telomeric transcriptome comprising telomeric repeat-containing RNA (TERRA) molecules. In mammalian cells, TERRA remains associated with telomeres after its transcription, and this association is regulated by SMG proteins, renowned for their involvement in several RNA metabolism pathways. The three SMG factors UPF1, hEST1A and SMG1, which have been associated with DNA stability networks before, also seem to be crucial to guarantee telomere integrity. Here, we review the current knowledge available of TERRA and on the role of SMG proteins in maintaining genome stability. We also propose an integrative model illustrating a putative link between telomere integrity, TERRA and SMG proteins. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19188687     DOI: 10.1159/000167804

Source DB:  PubMed          Journal:  Cytogenet Genome Res        ISSN: 1424-8581            Impact factor:   1.636


  23 in total

1.  CpG-island promoters drive transcription of human telomeres.

Authors:  Solomon G Nergadze; Benjamin O Farnung; Harry Wischnewski; Lela Khoriauli; Valerio Vitelli; Raghav Chawla; Elena Giulotto; Claus M Azzalin
Journal:  RNA       Date:  2009-10-22       Impact factor: 4.942

Review 2.  Nonsense-mediated mRNA decay in human cells: mechanistic insights, functions beyond quality control and the double-life of NMD factors.

Authors:  Pamela Nicholson; Hasmik Yepiskoposyan; Stefanie Metze; Rodolfo Zamudio Orozco; Nicole Kleinschmidt; Oliver Mühlemann
Journal:  Cell Mol Life Sci       Date:  2009-10-27       Impact factor: 9.261

3.  Promoting transcription of chromosome ends.

Authors:  Benjamin O Farnung; Elena Giulotto; Claus M Azzalin
Journal:  Transcription       Date:  2010-07-27

4.  A novel role for hSMG-1 in stress granule formation.

Authors:  James A L Brown; Tara L Roberts; Renee Richards; Rick Woods; Geoff Birrell; Y C Lim; Shigeo Ohno; Akio Yamashita; Robert T Abraham; Nuri Gueven; Martin F Lavin
Journal:  Mol Cell Biol       Date:  2011-09-12       Impact factor: 4.272

Review 5.  Molecular function and regulation of long non-coding RNAs: paradigms with potential roles in cancer.

Authors:  Mohammadreza Hajjari; Atefeh Khoshnevisan; Young Kee Shin
Journal:  Tumour Biol       Date:  2014-09-30

6.  Telomeric RNA-DNA hybrids affect telomere-length dynamics and senescence.

Authors:  Bettina Balk; André Maicher; Martina Dees; Julia Klermund; Sarah Luke-Glaser; Katharina Bender; Brian Luke
Journal:  Nat Struct Mol Biol       Date:  2013-09-08       Impact factor: 15.369

7.  Expression of telomeres in astrocytoma WHO grade 2 to 4: TERRA level correlates with telomere length, telomerase activity, and advanced clinical grade.

Authors:  Sandra Sampl; Sibylle Pramhas; Christian Stern; Matthias Preusser; Christine Marosi; Klaus Holzmann
Journal:  Transl Oncol       Date:  2012-02-01       Impact factor: 4.243

8.  Smg1 haploinsufficiency predisposes to tumor formation and inflammation.

Authors:  Tara L Roberts; Uda Ho; John Luff; C Soon Lee; Simon H Apte; Kelli P A MacDonald; Liza J Raggat; Allison R Pettit; Carl A Morrow; Michael J Waters; Phil Chen; Rick G Woods; Gethin P Thomas; Liam St Pierre; Camile S Farah; Raymond A Clarke; James A L Brown; Martin F Lavin
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-31       Impact factor: 11.205

9.  TERRA, CpG methylation and telomere heterochromatin: lessons from ICF syndrome cells.

Authors:  Zhong Deng; Amy E Campbell; Paul M Lieberman
Journal:  Cell Cycle       Date:  2010-01-01       Impact factor: 4.534

Review 10.  TERRA: telomeric repeat-containing RNA.

Authors:  Brian Luke; Joachim Lingner
Journal:  EMBO J       Date:  2009-07-23       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.